Abstract:Background and objective: The cysteine protease cathepsin K is elevated in both human and animal models of heart failure. Global deletion of cathepsin K attenuates both high fat diet- and pressure overload-induced cardiac hypertrophy and contractile dysfunction, although the role of cardiac cathepsin K remains unclear. To this end, the objective of this study was to generate a cardiomyocyte-specific knockout of cathepsin K ( Ctsk -/- ) and to test the hypothesis that deletion of cardiac cathepsin K protects against doxorubicin-induced cardiotoxicity. Methods: Ctsk -/- mice were generated by Ctsk targeted trap-allele including both FLP-FRT and Cre-lox systems. Cre-recombinase in myosin-heavy chain-Cre transgenic mice recognizes LoxP sites in “floxed (flanked by LoxP)” mice, and deletes the exons from 2 to 5 of Ctsk . Protein and mRNA levels of Ctsk and exon 2 were determined by Western blot and quantitative RT-PCR respectively. Four-months-old control (fl/fl-Cre - ) and Ctsk -/- (fl/fl-Cre + ) mice received two injections of doxorubicin (10mg/kg, i.p. at 3-day intervals, 20mg/kg cumulative), one week following which, body and tissue weight, echocardiographic properties, cardiomyocyte contractile function and Ca 2+ -handling were evaluated. Results: Cathepsin K mRNA and protein were attenuated by over 80% in the hearts of the knockout mice compared to the control. Doxorubicin injections resulted in an increase in total heart mass and the length of individual cardiomyocytes. Furthermore, doxorubicin-treated mice exhibited cardiomyocyte contractile dysfunction, characterized by depressed peak-shortening, maximal velocity of shortening and re-lengthening, and impaired intracellular Ca 2+ homeostasis. Additionally, mice receiving doxorubicin exhibited significant increases in end-systolic and end-diastolic diameters and decreased fractional shortening and wall thickness. These deleterious cardiac effects of doxorubicin were significantly attenuated or reversed in mice lacking cardiac cathepsin K. Conclusion: Mitigation of doxorubicin-induced cardiac anomalies by targeted deletion of cardiac cathepsin K suggests that cathepsin K represents a novel, bona-fide, pharmacological target for cardiac toxicity and complications.

Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.

Cathepsin K Knockout Mitigates High-Fat Diet–Induced Cardiac Hypertrophy and Contractile Dysfunction

Aliskiren Ameliorates Pressure Overload-Induced Heart Hypertrophy and Fibrosis in Mice

Cardiomyocyte-Specific Deletion of Cathepsin K Protects Against Doxorubicin-Induced Cardiac Dysfunction

Cardiomyocyte-specific Disruption of Cathepsin K Protects Against Doxorubicin-Induced Cardiotoxicity

Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.

Cathepsin B Deficiency Attenuates Cardiac Remodeling in Response to Pressure Overload Via TNF-α/ASK1/JNK Pathway

Cathepsin K knockout alleviates aging-induced cardiac dysfunction.

Cathepsin K knockout protects against cardiac dysfunction in diabetic mice

Cathepsin K activity controls cardiotoxin-induced skeletal muscle repair in mice.

Β-Adrenergic Activation May Promote Myosin Light Chain Kinase Degradation Through Calpain in Pressure Overload-Induced Cardiac Hypertrophy: Β-Adrenergic Activation Results in MLCK Degradation.

Lysosomal Cysteine Peptidase Cathepsin L Protects Against Cardiac Hypertrophy Through Blocking AKT/GSK3β Signaling

Novel Role for Caspase-Activated DNase in the Regulation of Pathological Cardiac Hypertrophy.

Casein Kinase-2 Interacting Protein-1 Regulates Physiological Cardiac Hypertrophy via Inhibition of Histone Deacetylase 4 Phosphorylation

The Expression of Cathepsin S, K and Cystatin C During the Left Ventricular Remodeling in Rats with Pressure Overloaded Myocardial Hypertrophy

A Cathelicidin-Related Antimicrobial Peptide Suppresses Cardiac Hypertrophy Induced by Pressure Overload by Regulating IGFR1/PI3K/AKT and TLR9/AMPKα

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking Eltd1

Amp Activated Protein Kinase-Alpha 2 Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice

Abstract P234: CTMP Negatively Regulates Pathological Cardiac Hypertrophy via Akt-dependent Manner

Cardiac-Specific EPI 64 C Blunts Pressure Overload – Induced Cardiac Hypertrophy

Deficiency of cysteinyl cathepsin K suppresses the development of experimental intimal hyperplasia in response to chronic stress